Crossref
Idarucizumab- and andexanet alfa-related DIC
Reactions Weekly · 28.03.2026 · 2103 (1) · 9-9
DOI: 10.1007/s40278-026-93395-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reactions Weekly, online erschienen am 28.03.2026. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Idarucizumab- and andexanet alfa-related DIC. Reactions Weekly, 2103(1), 9-9. https://doi.org/10.1007/s40278-026-93395-2
Vancouver
Idarucizumab- and andexanet alfa-related DIC. Reactions Weekly. 2026;2103(1):9-9. doi:10.1007/s40278-026-93395-2
BibTeX
@article{euvimed2026,
title = {Idarucizumab- and andexanet alfa-related DIC},
journal = {Reactions Weekly},
year = {2026},
volume = {2103},
number = {1},
pages = {9--9},
doi = {10.1007/s40278-026-93395-2}
}
EUVIMED